Monash Biotech
January 1st, 2025
The global In Vitro Fertilization (IVF) market is experiencing robust growth, driven by a confluence of significant factors.
The global IVF market size was valued at ₹ 2.5436 Trillion in 2024.
This market is projected to exhibit a significant Compound Annual Growth Rate (CAGR) of 8.80% during the forecast period (2024–2034).
By 2034, the market is anticipated to reach a substantial ₹ 5.91 Trillion.
Rising Infertility Rates : Globally, infertility rates are steadily increasing. This can be attributed to several factors, including:
Delayed Childbearing : Couples are increasingly delaying parenthood, often due to career advancements and other personal aspirations. However, female fertility naturally declines with age, increasing the likelihood of infertility.
Lifestyle Factors : Factors such as obesity, smoking, excessive alcohol consumption, and exposure to environmental toxins can significantly impact fertility in both men and women.
Increasing Prevalence of Chronic Diseases : The rising prevalence of chronic diseases, such as diabetes, endometriosis, and certain autoimmune disorders, can also contribute to infertility.
Continuous advancements in IVF techniques are driving market growth. These include:
Improved Embryo Culture Media : More sophisticated media that better mimic the in vivo environment enhance embryo development and improve success rates.
Time-Lapse Imaging : Allows for continuous monitoring of embryo development, providing valuable insights into embryo viability and selection.
Preimplantation Genetic Testing (PGT) : Enables the identification of chromosomal abnormalities and genetic diseases in embryos before implantation, increasing the likelihood of a successful pregnancy and reducing the risk of transmitting genetic disorders.
Minimally Invasive Techniques : Advancements in techniques like minimally invasive egg retrieval and embryo transfer enhance patient comfort and reduce procedure-related risks.